Back to Search
Start Over
MMP2 and MMP9 as candidate biomarkers to monitor bevacizumab therapy in high-grade glioma.
- Source :
-
Neuro-oncology [Neuro Oncol] 2015 Aug; Vol. 17 (8), pp. 1174-6. - Publication Year :
- 2015
- Subjects :
- Adult
Aged
Bevacizumab blood
Biomarkers, Tumor blood
Brain Neoplasms blood
Brain Neoplasms diagnosis
Disease Progression
Female
Glioblastoma blood
Glioblastoma diagnosis
Humans
Male
Middle Aged
Retrospective Studies
Treatment Outcome
Angiogenesis Inhibitors therapeutic use
Bevacizumab therapeutic use
Brain Neoplasms drug therapy
Glioblastoma drug therapy
Matrix Metalloproteinase 2 blood
Matrix Metalloproteinase 9 blood
Subjects
Details
- Language :
- English
- ISSN :
- 1523-5866
- Volume :
- 17
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Neuro-oncology
- Publication Type :
- Report
- Accession number :
- 26142442
- Full Text :
- https://doi.org/10.1093/neuonc/nov094